Next Article in Journal
Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
Next Article in Special Issue
P4 ATPases: Flippases in Health and Disease
Previous Article in Journal
A Molecular Dynamics Study of the Structural and Dynamical Properties of Putative Arsenic Substituted Lipid Bilayers
Previous Article in Special Issue
Structure and Conformational Dynamics of DMPC/Dicationic Surfactant and DMPC/Dicationic Surfactant/DNA Systems
Open AccessReview

Sphingomyelin in High-Density Lipoproteins: Structural Role and Biological Function

Departamento de Bioquímica y Biología Molecular y Celular, Facultad de Veterinaria, Instituto de Investigación Sanitaria de Aragón-Universidad de Zaragoza, Zaragoza E-50013, Spain
CIBER de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid E-28029, Spain
Departamento de Farmacología y Fisiología, Facultad de Ciencias de la Salud y del Deporte, Universidad de Zaragoza, Huesca E-22002, Spain
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2013, 14(4), 7716-7741;
Received: 19 February 2013 / Revised: 20 March 2013 / Accepted: 29 March 2013 / Published: 9 April 2013
(This article belongs to the Special Issue Phospholipids: Molecular Sciences 2012)
High-density lipoprotein (HDL) levels are an inverse risk factor for cardiovascular diseases, and sphingomyelin (SM) is the second most abundant phospholipid component and the major sphingolipid in HDL. Considering the marked presence of SM, the present review has focused on the current knowledge about this phospholipid by addressing its variable distribution among HDL lipoparticles, how they acquire this phospholipid, and the important role that SM plays in regulating their fluidity and cholesterol efflux from different cells. In addition, plasma enzymes involved in HDL metabolism such as lecithin–cholesterol acyltransferase or phospholipid transfer protein are inhibited by HDL SM content. Likewise, HDL SM levels are influenced by dietary maneuvers (source of protein or fat), drugs (statins or diuretics) and modified in diseases such as diabetes, renal failure or Niemann–Pick disease. Furthermore, increased levels of HDL SM have been shown to be an inverse risk factor for coronary heart disease. The complexity of SM species, described using new lipidomic methodologies, and their distribution in different HDL particles under many experimental conditions are promising avenues for further research in the future. View Full-Text
Keywords: high-density lipoproteins; phospholipids; sphingomyelin high-density lipoproteins; phospholipids; sphingomyelin
Show Figures

Graphical abstract

MDPI and ACS Style

Martínez-Beamonte, R.; Lou-Bonafonte, J.M.; Martínez-Gracia, M.V.; Osada, J. Sphingomyelin in High-Density Lipoproteins: Structural Role and Biological Function. Int. J. Mol. Sci. 2013, 14, 7716-7741.

AMA Style

Martínez-Beamonte R, Lou-Bonafonte JM, Martínez-Gracia MV, Osada J. Sphingomyelin in High-Density Lipoproteins: Structural Role and Biological Function. International Journal of Molecular Sciences. 2013; 14(4):7716-7741.

Chicago/Turabian Style

Martínez-Beamonte, Roberto; Lou-Bonafonte, Jose M.; Martínez-Gracia, María V.; Osada, Jesús. 2013. "Sphingomyelin in High-Density Lipoproteins: Structural Role and Biological Function" Int. J. Mol. Sci. 14, no. 4: 7716-7741.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop